Anti-aggregation therapy in patients with acute coronary syndrome — recommendations for medical emergency teams. Experts’ standpoint (original) (raw)

AI-generated Abstract

This paper discusses the critical role of antiplatelet therapy in managing acute coronary syndrome (ACS), focusing on P2Y12 receptor antagonists, which are essential in preventing thrombus formation. It emphasizes the need for medical emergency teams to understand the appropriate recommendations for these therapies, highlighting the potential contraindications and considerations necessary for their effective use in acutely ill patients. Furthermore, the paper examines the epidemiology of cardiovascular diseases, particularly ischaemic heart disease, and the importance of timely and effective treatment strategies in reducing mortality associated with myocardial infarction.

Sign up for access to the world's latest research.

checkGet notified about relevant papers

checkSave papers to use in your research

checkJoin the discussion with peers

checkTrack your impact